Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where enhanced metabolic stability and bioavailability are required. Its structure supports the introduction of fluorinated aromatic motifs that improve drug-receptor binding and resistance to oxidative degradation. Commonly employed in the preparation of anti-inflammatory, antidiabetic, and central nervous system agents. Also utilized in agrochemicals for creating fluorinated pesticides and herbicides due to improved lipophilicity and environmental persistence. Suitable for use in liquid-phase organic synthesis and catalytic coupling reactions.